Effect of Montelukast on Remodelling Markers in Asthmatic Children

NCT00875082 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Montelukast
DRUG: placebo

Sponsor

Universita di Verona